Tiny Injectable Device Could Transform Treatment for Chronic Pain and Nerve Disorders
Chronic pain and neurological conditions may pose a challenge to patients due to the fact that nerves that are involved in feeling pain, movement, and sensation are located deep within the body. Current methods of neuromodulation can be effective for patients but often require surgically inserted leads, pulse generators, batteries, and other components.
Now, scientists from New York University Abu Dhabi (NYU Abu Dhabi) together with researchers from Cleveland Clinic Abu Dhabi have invented a tiny seed-like device that can deliver electrical stimulation to peripheral nerves without surgery, wires, or a surgically implanted battery. The technology, named SEED, was unveiled by the researchers in a study published in Science Advances in June 2026. Notably, the SEED device has been tested in laboratories and on animals so far.
What Is The New Injectable Nerve-Stimulation Device?
The system has been designed for delivering peripheral neuromodulation, a process where electrical stimulation is provided to nerves that lie outside the brain and spinal cord. Unlike other methods where a surgical implantation is required, SEED has been designed in such a way that it can be delivered via a regular 14-gauge needle in the proximity of a targeted peripheral nerve.
In designing the system, scientists have not used any battery or other forms of active electronics within the system. The wireless energy is provided to the system through the resonant inductive coupling method from outside the body. The electrical stimulation, along with control, is provided from the external system, and the signal is delivered to the nerve through the implanted system.
How Does The Technology Work?
SEED is a shortened name for Stimulating Electrode for Electroceutical Delivery. It is powered by means of wireless energy transfer and electrical stimulation.
The scientists used a low-frequency electromagnetic field of about 65 kilohertz to transfer energy to the implanted device. Since the control and stimulation waveform happen outside of the body, there is no need for a power source or any electronic circuitry inside this small device. This feature is especially relevant for making the device small enough to be inserted through a needle.
The electrode of the device has a special spiral-helix design which allows longitudinal stimulation of the nerve and minimizes the unnecessary stimulation of other tissues. Researchers found it possible to regulate such important parameters of stimulation as the frequency, pulse width, and amplitude of the stimulation waveform.
It is essential since different nerve fibres may react differently to the electrical stimulation, and different parameters of stimulation may recruit different fibres.
What Did The Researchers Discover?
This research entailed both lab testing and animal experiments. The programmable control of the electrical stimulation generated by the device under physiological conditions was shown through bench and ex-ex vivoperiments.
The most convincing findings involved an in vivo rat model using the sciatic nerve. The device generated frequency-dependent motor responses and graded neural recruitment after its percutaneous implantation into the body. In other words, researchers managed to use a wireless device to stimulate the peripheral nerve and elicit a response.
Moreover, the authors mentioned that the device could be visualized using medical imaging because it had radiopacity and acoustic contrast properties. Thus, it was compatible with computed tomography (CT) and ultrasonography. This property will allow clinicians in the future to locate and properly place a device in the body.
These results should not be considered too seriously. It is essential to prove that nerve stimulation in rats may become a basis for a therapy for humans.
Why Could This Matter For Chronic Pain?
Even after healing from the injury or the underlying disorder, chronic pain may continue due to changes in the peripheral and central nervous systems, which might contribute to abnormal pain signaling. In cases where normal medical treatment proves to be ineffective or may result in side effects, neuromodulation approaches are explored for their ability to affect the nervous system directly.
One of the ways that may help manage pain is the use of peripheral nerve stimulation (PNS). As opposed to the administration of medication, PNS makes use of electrical stimulation of a particular peripheral nerve. PNS review papers have demonstrated promising outcomes of its use in certain types of chronic pain, but efficiency varies greatly.
In addition to efficiency, the SEED technology seems to be important because it seeks to make neuromodulation less invasive. This is because the implantation procedure is conducted through a needle, and there is no need for an incision or for a power source to be placed inside the body.
Possible Benefits Of The Technology
Providing that future tests on humans will prove its safety and efficacy, such a device could possess some benefits, including:
Minimal invasion during the process of insertion: SEED is created to be inserted percutaneously via a 14-gauge needle.
Lack of the internal battery: Wireless energy supply makes the use of the internal battery unnecessary.
Lack of connecting wire: Such technology doesn’t involve the use of a connecting wire connected to a pulse generator.
Frequency, pulse width, and amplitude are programmable. Such characteristics could be extremely helpful for people who need stimulation of the peripheral nerve but can’t be considered good candidates for bigger implanted devices.
What Makes SEED Differ From Traditional Neuromodulation Systems?
Existing neuromodulation systems already represent a valuable therapeutic choice for some specific patients. For instance, spinal cord stimulation includes placing electrodes that produce electrical impulses near the spine in the treatment of some chronic pains.
Peripheral nerve stimulation is also more specific and allows targeting nerves outside the spinal cord when it is possible for clinicians to specify a particular nerve or area responsible for a patient’s pain.
However, the main difference between SEED and other neuromodulation systems is in the physical design and the method of power supply. While traditional implantable neuromodulators include the ianantable electrode connected to a larger pulse generator via the lead, SEED receives energy from an external source without any cables. The scientists refer to it as a bridge between implantable and wearable neuromodulation systems.
This does not mean that SEED is now better than other neuromodulation systems. While existing devices have been clinically developed and evaluated, SEED is only at the preclinical research stage.
Could It Have Applications In Treating Nerve Disorders Other Than Pain?
The possible uses could go beyond chronic pain, as peripheral nerves not only transmit the sensation of pain, but also regulate many bodily functions, including movement and communication between the brain, spinal cord, and body parts.
The researchers showed that SEED was capable of inducing controlled movements in rats via stimulation of the sciatic nerve. Thus, there is proof that the technology not only transmits an electrical signal, but can affect the activity of nerves and induce a physiological reaction.
In the future, researchers may explore if the technology could be used to treat some neurological or motor disorders that may benefit from targeted peripheral nerve stimulation.
The possible directions of investigation may include:
– Neuropathic or other chronic pain conditions
– Motor dysfunction disorders
– Peripheral nerve rehabilitation
– Other disorders in which targeted neuromodulation could affect abnormal neural activity.
However, one should consider these as potential directions of research, not as a treatment for some neurological disorder such as paralysis, Parkinson’s disease, chronic pain, or anything else.
Why Is The Battery-Free Approach So Important?
A key issue with implanted electronic devices is the need for power while minimizing the size and ensuring the safety of the implant.
In the case of traditional implants, batteries may be needed and add to the volume, as well as eventually needing to be changed or recharged. Thus, removing the battery can help minimize the size of the implant and even improve its architecture.
Instead of the battery approach, SEED uses resonant inductive coupling. This means that the power is delivered through electromagnetic waves generated by the transmitter outside the body. In this particular experiment, the researchers operated at around 65 kHz and used the electromagnetic field to control the stimulation.
Battery-free implantable electronics are one of the topics being actively researched in the field of biomedical engineering because they promise to be smaller and require less use of an implantable energy source. However, wireless powering comes with new challenges too.
What Does It Mean for Patients Today?
In terms of chronic pain or neurological conditions, there is some good news here, although SEED is not an available solution today.
The technology was demonstrated through lab work and tests on a rat sciatic nerve in the Science Advances paper published in June 2026. Scientists managed to achieve wireless activation, programming, stimulation, and measurement of the motor response after the percutaneous implantation of SEED into the nerve tissue.
This is a very important point: an innovative piece of equipment cannot be sold as an established treatment yet. The differences between the human body, the reactions of the nerves, and the behavior of the implant inside the body can be quite significant.
For now, people experiencing chronic pain will have to discuss existing treatments instead of implanting a novel implant without proper trials.
References:
Cite this article
Bhavini Patidar (2026). Tiny Injectable Device Could Transform Treatment for Chronic Pain and Nerve Disorders. Independent Writer. https://independentwriter.in/injectable-nerve-stimulation-device-chronic-pain/
